111
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Assessing the Clinical Utility of Point of Care HbA1c in the Ophthalmology Outpatient Setting

ORCID Icon, ORCID Icon, ORCID Icon, &
Pages 41-47 | Published online: 07 Jan 2021

References

  • Liew G, Michaelides M, Bunce C. A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010. BMJ Open. 2014;4:e004015. doi:10.1136/bmjopen-2013-004015
  • Frank RN. Systemic therapies for diabetic retinopathy: the accord eye study. Ophthalmology. 2014;121(12):2295–2296. doi:10.1016/j.ophtha.2014.08.019
  • Yau JWY, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556–564. doi:10.2337/dc11-1909
  • Delamater AM. Improving patient adherence. Clin Diabetes. 2006;24:71–77. doi:10.2337/diaclin.24.2.71
  • Anderson RM, Fitzgerald JT, Oh MS. The relationship between diabetes-related attitudes and patients’ self- reported adherence. Diabetes Educ. 1993;19:287–292. doi:10.1177/014572179301900407
  • Harris MI. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care. 2001;24:979–982. doi:10.2337/diacare.24.6.979
  • Driskell OJ, Holland D, Waldron JL, et al. Reduced testing frequency for glycated hemoglobin, HbA1c, is associated with deteriorating diabetes control. Diabetes Care. 2014;37:2731–2737. doi:10.2337/dc14-0297
  • National Institute for Health and Care Excellence. Overview | type 2 diabetes in adults: management | guidance | NICE. Type 2 diabetes adults Manag. 2019. Available from: https://www.nice.org.uk/guidance/ng28. Accessed April 26, 2020.
  • Aiello LP, Ayala AR, Antoszyk AN, et al. Assessing the effect of personalized diabetes risk assessments during ophthalmologic visits on glycemic control: a randomized clinical trial. JAMA Ophthalmol. 2015;133:888–896. doi:10.1001/jamaophthalmol.2015.1312
  • Public Health England. NHS Diabetic Eye Screening Programme. NHS Diabet. Eye Screen. Program. 2016. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/505587/DES_07_GP_information_sheet_March_2016.pdf. Accessed April 26, 2020.
  • Ramsay LE, Williams B, Johnston GD, et al. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens. 1999;13:569–592. doi:10.1038/sj.jhh.1000917
  • Hunt LM, Arar NH, Larme AC. Contrasting patient and practitioner perspectives in Type 2 diabetes management. West J Nurs Res. 1998;20:656–682. doi:10.1177/019394599802000602
  • Loewe R, Freeman J. Interpreting diabetes mellitus: differences between patient and provider models of disease and their implications for clinical practice. Cult Med Psychiatry. 2000;24:379–401. doi:10.1023/A:1005611207687.
  • Sicard DA, Taylor JR. Comparison of point-of-care HbA 1c test versus standardized laboratory testing. Ann Pharmacother. 2005;39:1024–8. doi:10.1345/aph.1E504.
  • Kennedy L, Herman WH, Strange P, et al. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial. Diabetes Care. 2006;29:1–8. doi:10.2337/diacare.29.01.06.dc05-1058